Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

Yuan Cheng; He Cai; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei

doi:10.1038/s41392-019-0095-0

Keywords

EpigeneticsClinical trialCancerCancer therapyEpigenetic therapyComputational biologyEpigenesisMedicineBioinformaticsBiologyGeneticsInternal medicineDNA methylation

Affiliated Institutions

Related Publications

Concepts of epigenetics in prostate cancer development

Christopher S. Cooper , Christopher S. Foster

Substantial evidence now supports the view that epigenetic changes have a role in the development of human prostate cancer. Analyses of the patterns of epigenetic alteration are...

2008 British Journal of Cancer 105 citations

Histone acetylation and an epigenetic code

Bryan M. Turner

The enzyme-catalyzed acetylation of the N-terminal tail domains of core histones provides a rich potential source of epigenetic information. This may be used both to mediate tra...

2000 BioEssays 1168 citations

DNA methylation-based biomarkers and the epigenetic clock theory of ageing

Steve Horvath , Kenneth Raj

Identifying and validating molecular targets of interventions that extend the human health span and lifespan has been difficult, as most clinical biomarkers are not sufficiently...

2018 Nature Reviews Genetics 2904 citations

Molecular Signals of Epigenetic States

Roberto Bonasio , Shengjiang Tu , Danny Reinberg

Epigenetic signals are responsible for the establishment, maintenance, and reversal of metastable transcriptional states that are fundamental for the cell’s ability to “remember...

2010 Science 891 citations

Targeting PI3K in cancer: mechanisms and advances in clinical trials

Jing Yang , Ji Nie , Xuelei Ma +3 more

Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling is one of the most important intracellular pathways, which can be considered as a master ...

2019 Molecular Cancer 1491 citations

Publication Info

Year: 2019
Type: review
Volume: 4
Issue: 1
Pages: 62-62
Citations: 1022
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1022

OpenAlex

Cite This

APA Style

                            
                                
                                    Yuan Cheng, 
                                
                                    He Cai, 
                                
                                    Manni Wang
                                
                                et al.
                            
                            (2019). 
                            Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. 
                            Signal Transduction and Targeted Therapy
                            , 4
                            (1)
                            , 62-62.
                            https://doi.org/10.1038/s41392-019-0095-0
                        

Identifiers

DOI: 10.1038/s41392-019-0095-0